Metrion Biosciences
PrivateLast Round
VC Round
Dec 4, 2023
Total Funding Raised
$1.49M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Metrion Biosciences is a contract research organization that provides ion channel drug discovery, cardiac safety screening, and neuroscience services.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metrion Biosciences Comparables
Compare Metrion Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| B'SYS GmbH | 85% | |
| ApconiX | 83% | |
| Neuroservices-Alliance | 82% |
Metrion Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 4, 2023 | ||||
| VC Round | Apr 6, 2021 | ||||
| Seed | Mar 14, 2019 | ||||
| Grant | Aug 28, 2018 | ||||
| Grant | Feb 5, 2018 |
Key People
Founding team and executive leadership
Metrion Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | Seed |
| Innovate UK | Grant |
| Gresham House Ventures | VC Round |
| Maven Capital Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 8, 2.5x the trailing average.
- Apr 20, 2026
Monthly visitors increased 58% MoM.
Metrion Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access